In this article, we first reviewed the action and uses of agonists and antagonists of LH-RH, and we will now review the development of agonists and antagonists of GH-RH before focusing on their application as single or combined agents for the treatment of BPH. This evidence concerns the gene GNRH1 and benign prostatic hyperplasia.